Stocks
GlaxoSmithKline (GSK) ROA US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | 8.18% | 24.9% | 8.18% | 8.35% | 8.35% | 3.62% | ||
| Changes by years, y/y, % | +3pp | +17pp | -17pp | +0pp | 0pp | +6.0% | |||
GlaxoSmithKline. ROA, %
GlaxoSmithKline. ROA, changes, pp
GlaxoSmithKline (GSK) ROA US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROA, % | ? | 7.72% | 7.66% | 6.95% | 6.95% | 4.33% | 3.62% | |
| Changes by years, y/y, % | -1pp | 0pp | -3pp | -2pp | -6pp | |||
| Changes by quarters, q/q, % | -1pp | 0pp | -1pp | 0pp | -3pp | |||
